Title of article
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohnʹs disease: an open randomised trial
Author/Authors
Geert DʹHaens، نويسنده , , Filip Baert، نويسنده , , Gert van Assche، نويسنده , , Philip Caenepeel، نويسنده , , Philippe Vergauwe، نويسنده , , Hans Tuynman، نويسنده , , Martine De Vos، نويسنده , , Sander van Deventer، نويسنده , , Larry Stitt، نويسنده , , Allan Donner، نويسنده , , Severine Vermeire، نويسنده , , Frank J Van De Mierop، نويسنده , , Jean-Charles R Coche، نويسنده , , Janneke van der Woude، نويسنده , , Thomas O، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
8
From page
660
To page
667
Abstract
Background
Most patients who have active Crohnʹs disease are treated initially with corticosteroids. Although this approach usually controls symptoms, many patients become resistant to or dependent on corticosteroids, and long exposure is associated with
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
592533
Link To Document